Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC70
TNBC
Basal A
LBH589
HDAC
HDAC
10873.154
uM
0.07768
0.13103
-0.9534 -0.9626 2.0534 0.8487
0.9994
1.1648
HCC70
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12400.167
uM
0.16431
0.49313
-0.9570 -0.8404 0.8972 0.5972
0.9772
1.2627
HCC70
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10873.154
uM
0.24958
1.13010
-0.9565 -1.0000 0.7274 0.5386
0.9918
1.1648
HCC70
TNBC
Basal A
Mebendazole
12714.174
uM
0.11165
0.17592
-0.9403 -0.8934 2.2542 1.0180
0.9090
0.3306
HCC70
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7470.085
uM
inf
inf
0.6898 0.6898 0.0000 0.2374
0.0000
0.9880
HCC70
TNBC
Basal A
Methylglyoxal
13607.184
uM
inf
inf
-0.7097 -0.7097 0.0000 0.5913
0.5266
0.8612
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
14257.189
uM
inf
inf
-1.0000 -1.0000 0.0000 0.9813
0.4558
0.3775
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
14257.189
uM
inf
inf
-1.0000 -1.0000 0.0000 0.9813
0.4558
0.3775
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
12400.17
uM
0.07474
0.11640
-0.9170 -0.9300 2.3720 0.9712
0.9984
1.1992
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
12400.17
uM
0.07474
0.11640
-0.9170 -0.9300 2.3720 0.9712
0.9984
1.1992
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
10873.145
uM
0.06136
0.10266
-0.9226 -0.9290 2.0405 0.9792
0.9990
1.2454
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
10873.145
uM
0.06136
0.10266
-0.9226 -0.9290 2.0405 0.9792
0.9990
1.2454
HCC70
TNBC
Basal A
Pevonedistat
NAE1
NAE1
10873.148
uM
inf
inf
0.9161 0.9161 0.0000 0.1719
0.0430
1.2150
HCC70
TNBC
Basal A
Pevonedistat
NAE1
NAE1
12400.135
uM
0.15813
0.25123
-0.8344 -0.8087 2.0783 0.7902
0.9996
1.2966
HCC70
TNBC
Basal A
Nelfinavir
12714.174
uM
8.95410
11.15450
-1.0000 -1.0000 5.0000 0.3201
0.8734
0.3306
HCC70
TNBC
Basal A
Nilotinib
ABL
nRTK
12400.17
uM
inf
inf
1.0500 1.0500 0.0000 -0.0014
-0.0040
1.1992
HCC70
TNBC
Basal A
Nilotinib
ABL
nRTK
10873.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0001
-0.0012
1.2454
HCC70
TNBC
Basal A
NSC 663284
CDC25
CDC
10873.152
uM
2.85030
5.92010
-0.9625 -1.0000 1.5031 0.5523
0.9855
1.1577
HCC70
TNBC
Basal A
NSC 663284
CDC25
CDC
12400.152
uM
3.32670
5.80610
-0.9357 -0.9641 1.9291 0.5522
0.9942
1.1392
HCC70
TNBC
Basal A
NU6102
CDK1/2
CDK
12400.147
uM
18.83870
25.10
-0.9561 -1.0000 3.8285 0.2311
0.9581
1.2599
HCC70
TNBC
Basal A
NU6102
CDK1/2
CDK
10873.147
uM
15.06980
21.86720
-0.9426 -1.0000 2.9509 0.2344
0.9694
1.2965
HCC70
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7470.066
uM
16.9690
35.8280
-0.4446 -1.0000 1.4700 0.2042
0.9482
1.0766
HCC70
TNBC
Basal A
Olomoucine II
CDK1
CDK
10873.147
uM
4.03480
6.95720
-0.9564 -1.0000 2.0165 0.5074
0.9908
1.2965
HCC70
TNBC
Basal A
Olomoucine II
CDK1
CDK
12400.147
uM
3.99480
6.76650
-0.9567 -1.0000 2.0848 0.5109
0.9923
1.2599
HCC70
TNBC
Basal A
Omipalisib
PI3K
PI3K
7470.086
uM
0.00760
0.02508
-0.9413 -0.9203 0.8740 1.0811
0.9950
0.9669